New Delhi. The Rs 400 crore IPO of GSP Crop Science, a company working in the agrochemical sector, was launched for subscription today. Bidding in this IPO can be done till March 18.
After the closing of the issue, the allotment of shares will be done on March 20, while the allotted shares will be credited to the demat account on March 23. The company’s shares may be listed on BSE and NSE on March 24.
The price band for bidding in this IPO has been fixed at Rs 304 to Rs 320 per share, while the lot size is 46 shares. In this IPO, retail investors can bid for at least 1 lot i.e. 46 shares, for which they will have to invest Rs 14,720.
Similarly, retail investors can bid for 598 shares in a maximum of 13 lots with an investment of Rs 1,91,360. Under this IPO, a total of 1.25 shares with face value of Rs 10 are being issued. Of these, 75 lakh new shares worth Rs 240 crore and 50 lakh shares worth Rs 160 crore are being sold through the offer for sale window.
A maximum of 50 percent share has been reserved for Qualified Institutional Buyers (QIB) in this IPO. Apart from this, minimum 35 percent share is reserved for retail investors and minimum 15 percent share is reserved for non-institutional investors (NIIs).
Equirus Capital Private Limited has been appointed as the book running lead manager for this issue, while MUGF Intime India Private Limited has been appointed as the registrar. Talking about the financial condition of the company, as per the claim made in the Draft Red Herring Prospectus (DRHP) submitted to the capital market regulator SEBI, its financial health has continuously strengthened.
In the financial year 2022-23, the company had a net profit of Rs 17.57 crore, which increased to Rs 55.54 crore in the next financial year 2023-24 and jumped to the level of Rs 81.42 crore in the financial year 2024-25. The company has made a net profit of Rs 81.07 crore in the first half of the current financial year i.e. from April to September 30, 2025.
During this period, there were slight fluctuations in the company’s revenue receipts. It received a total revenue of Rs 1,206.05 crore in the financial year 2022-23, which decreased to Rs 1,158.23 crore in the financial year 2023-24 and jumped to Rs 1,301.06 crore in the financial year 2024-25.
In the first half of the current financial year i.e. from April to September 30, 2025, the company has received a revenue of Rs 847.61 crore.
During this period, the debt burden of the company also kept fluctuating. At the end of the financial year 2022-23, the company had a debt burden of Rs 324.26 crore, which reduced to Rs 235.44 crore in the financial year 2023-24 and increased to Rs 296.60 crore in the financial year 2024-25.
If we talk about the first half of the current financial year i.e. from April to September 30, 2025, during this period the debt burden on the company came to the level of Rs 321.13 crore. The reserves and surplus of the company also increased during this period.
In the financial year 2022-23, it was at the level of Rs 336 crore, which increased to Rs 344.46 crore in 2023-24. Similarly, in 2024-25, the reserve and surplus of the company came to the level of Rs 411.02 crore. Whereas in the first half of the current financial year i.e. from April to September 30, 2025, it reached the level of Rs 490.84 crore.
Similarly, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization) was at the level of Rs 81.28 crore in 2022-23, which increased to Rs 130.41 crore in 2023-24.
Similarly, in 2024-25, the EBITDA of the company came to the level of Rs 164.03 crore. Whereas in the first half of the current financial year i.e. from April to September 30, 2025, it was at the level of Rs 138.86 crore.
Comments are closed.